NCT06997029 2026-04-07
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Recruiting
Bristol-Myers Squibb
The Netherlands Cancer Institute
Peter MacCallum Cancer Centre, Australia
Shanghai Changzheng Hospital
Georgetown University
University of California, San Diego